Evidence map›Paper›PMID 23512348›Full record

ReviewIUBMB life2013

Obscurins: unassuming giants enter the spotlight.

Nicole A Perry, Maegen A Ackermann, Marey Shriver, Li-Yen R Hu, Aikaterini Kontrogianni-Konstantopoulos

Abstract readReview
In one paragraph

Review in IUBMB life, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. The varied functions of the giant muscle scaffold protein obscurin.Frontiers in cell and developmental biology · 2025
    Review
  2. Article
  3. Article
  4. PK1 fromOpen biology · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Obscurin: A multitasking giant in the fight against cancer.Biochimica et biophysica acta. Reviews on cancer · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Obscurin is a semi-flexible molecule in solution.Protein science : a publication of the Protein Society · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nicole A PerryDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Maegen A Ackermann
Marey Shriver
Li-Yen R Hu
Aikaterini Kontrogianni-Konstantopoulos
University of Maryland, Baltimore · US

Funding

Interdisciplinary Training Program Muscle BiologyT32AR007592 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Aikaterini Kontrogianni-Konstantopoulos · 1996 to 2026
$11.7M
Novel Locations; Familiar Functions: Obscurin at the Cardiac Intercalated DiscK99HL116778 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BORZOK, MAEGEN A. · 2013 to 2014
$257k
NHLBI NIH HHS K99 HL116778NIAMS NIH HHS T32 AR007592
6 · The paper itself

Abstract

Discovered about a decade ago, obscurin (~720 kDa) is a member of a family of giant proteins expressed in striated muscle that are essential for normal muscle function. Much of what we understand about obscurin stems from its functions in cardiac and skeletal muscle. However, recent evidence has indicated that variants of obscurin ("obscurins") are expressed in diverse cell types, where they contribute to distinct cellular processes. Dysfunction or abrogation of obscurins has also been implicated in the development of several pathological conditions, including cardiac hypertrophy and cancer. Herein, we present an overview of obscurins with an emphasis on novel findings that demonstrate their heretofore-unsuspected importance in cell signaling and disease progression.

Indexed as

AnimalsCardiomyopathy, Hypertrophic, FamilialHumansMuscle DevelopmentMuscle, SkeletalMutation, MissenseNeoplasmsOrgan SpecificityProtein Interaction MapsProtein Serine-Threonine KinasesRho Guanine Nucleotide Exchange FactorsOBSCN protein, humanProtein Serine-Threonine KinasesRho Guanine Nucleotide Exchange Factorsbreast cancercardiac hypertrophyOBSCNobscurinstriated muscleUNC-89

Identifiers

PMID23512348
PMCPMC3957234
OpenAlexW1974554762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.